✦ LIBER ✦

A Phase I Clinical Trial of the Treatment of Crohn’s Fistula by Adipose Mesenchymal Stem Cell Transplantation

✍ Scribed by Damián García-Olmo; Mariano García-Arranz; Dolores Herreros; Isabel Pascual; Concepción Peiro; José Antonio Rodríguez-Montes

Publisher: Springer
Year: 2005
Tongue: English
Weight: 333 KB
Volume: 48
Category: Article
ISSN: 0012-3706
DOI: 10.1007/s10350-005-0052-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Autologous stem cell transplantation for

Autologous stem cell transplantation for treatment of rectovaginal fistula in perianal Crohn's disease: a new cell-based therapy

✍ Damian García-Olmo; Mariano García-Arranz; Lourdes Gómez García; Eduardo Serna C 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 205 KB

Treatment of enterocutaneous fistula in

Treatment of enterocutaneous fistula in Crohn’s Disease with adipose-derived stem cells: a comparison of protocols with and without cell expansion

✍ Damian Garcia-Olmo; Dolores Herreros; Maria Pascual; Isabel Pascual; Paloma De-L 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 94 KB

A randomized, controlled clinical trial

A randomized, controlled clinical trial of the homeopathic medication TRAUMEEL s® in the treatment of chemotherapy-induced stomatitis in children undergoing stem cell transplantation

✍ Menachem Oberbaum; Isaac Yaniv; Yael Ben-Gal; Jerry Stein; Nurit Ben-Zvi; Lauren 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

Phase I/II trial of cure-oriented high-d

Phase I/II trial of cure-oriented high-dose chemoradiotherapy with transplantation of CD34+ peripheral blood stem cells purified by the immunomagnetic bead method for refractory hematological malignancies

✍ Michinori Ogura; Yoshitoyo Kagami; Ritsuro Suzuki; Kazuhisa Miura; Kazutaka Uehi 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 141 KB

A Phase I dose escalation trial of conti

A Phase I dose escalation trial of continuous infusion paclitaxel to augment high dose cyclophosphamide and thiotepa plus stem cell rescue for the treatment of patients with advanced breast carcinoma

✍ Todd M. Zimmerman; David L. Grinblatt; Rebecca Malloy; Stephanie F. Williams 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 2 views

## BACKGROUND. Paclitaxel, an effective chemotherapeutic agent in the management of breast carcinoma, may have activity in women whose disease has recurred after high dose chemotherapy. With this is mind the authors explored the addition of a 120-hour continuous infusion of paclitaxel to a previou

Phase I/II trial of paclitaxel by 1-hour

Phase I/II trial of paclitaxel by 1-hour infusion, carboplatin, and gemcitabine in the treatment of patients with advanced nonsmall cell lung carcinoma

✍ John D. Hainsworth; Howard A. Burris III; Joan B. Erland; Lisa H. Morrissey; Ant 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 3 views

## BACKGROUND. The combination of paclitaxel and carboplatin is widely used in the treatment of patients with advanced nonsmall cell lung carcinoma. In this Phase I/II study the authors evaluated the feasibility, toxicity, and efficacy of adding a third active antineoplastic agent, gemcitabine, to